Since TWEAK treatment of glioma [62], prostate cancer [48] and melanoma [55] cells in vitro has been shown previously to increase Fn14 gene expression, we first analyzed Fn14 protein levels in the four B16 cell lines using Western blot analysis. Here, TNFRSF12A is linked to glioma.